Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Inflammation damages sweat ducts, causing sweat gland injury.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Fetal skin has unique immune cells different from adult skin.

Biological factors are crucial for developing new hair restoration treatments.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.

Platycladi Cacumen may help treat hair loss by affecting certain biological pathways.

D'orenone stops root hair growth by disrupting auxin transport, but adding auxin can reverse this.

Cepharanthine shows promise as a COVID-19 treatment.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

New therapies are being developed that target integrin pathways to treat various diseases.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Hair transplant can cause hard-to-treat keloids in some patients.